Results for untargeted MS search on m/z: (+/-) mode
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN000078 | Phenylsulfate | 0.78 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Purine | 0.81 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | edetate | 0.81 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | VALDECOXIB | 0.81 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 3-Dehydroquinicacid | 0.82 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Diphenylmethylphosphine | 0.82 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 6-(2-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)-1-PHENYL-2-THIOBIUREA | 0.82 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | DL-Ornithine | 0.82 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PheGlyThr | 0.83 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glutaconicacid | 0.83 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Succinicanhydride | 0.84 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Histamine | 0.84 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Histidine | 0.84 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Mannitol | 0.84 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Chloralhydrate | 0.85 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | N(pai)-Methyl-L-histidine | 0.85 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Arginine | 0.86 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PhePhe | 0.86 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | TrpMet | 0.86 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | GlyHisAsn | 0.87 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | AspHis | 0.87 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | B-ureidoisobutyricacid | 0.87 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyroglutamicacid | 0.87 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Oxaloglutarate | 0.87 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Gluconicacid | 0.88 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 6-(2-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)-1-PHENYL-2-THIOBIUREA-0.88713235 | 0.89 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Citrulline | 0.89 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | D-Homoserine | 0.9 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glycolaldehyde | 0.9 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Dihydroxyacetone(glycerone) | 0.9 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Methylglyoxal | 0.9 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Chloramphenicolalcohol | 0.91 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Galactonicacid | 0.91 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | VALDECOXIB-0.9111763 | 0.91 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ISOEUGENITOL | 0.91 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glycolicacid | 0.91 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Chlorogenicacid | 0.92 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | S-(p-Azidophenacyl)glutathione | 0.92 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Isorhamnetin | 0.92 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | OXOLINICACID | 0.92 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | L-gamma-Cyano-gamma-aminobutyricacid | 0.92 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | N-Acetylgalactosamine4-sulphate | 0.92 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | IdebenoneMetabolite(Benzenebutanoicacid,2-hydroxy-3,4-dimethoxy-6-methyl-5-(sulfooxy)-) | 0.92 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Arabinose | 0.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-Naphthylbeta-D-glucuronide | 0.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | TyrTyrMet | 0.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | SerPro | 0.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ProAsp | 0.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Adipamide | 0.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Penicillaminedisulfide | 0.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | MIGLITOL | 0.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Ne-Methyl-L-lysine | 0.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | edetate-0.93380904 | 0.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | D-Glucose | 0.94 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Creatine | 0.95 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | beta-Alanine | 0.95 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glycericacid | 0.95 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PYROGALLIN | 0.96 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyruvicacid | 0.96 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Proline | 0.97 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Ribulose | 0.98 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glutaconicacid-0.98035145 | 0.98 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-Keto-glutaramicacid | 1 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Diacetyl | 1.02 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Furan2,5-dicarboxylicacid | 1.02 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Dehydroascorbicacid | 1.02 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | (S)-2-Hydroxyglutarate | 1.02 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | threo-Isocitricacid | 1.02 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Erythrono-1,4-lactone | 1.02 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-Furoicacid | 1.02 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | EPIGALLOCATECHIN | 1.03 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Citraconicacid | 1.03 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glyoxylicacid | 1.03 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ValGly | 1.04 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Chlorpropamide | 1.04 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Fumaricacid | 1.04 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Methylglyoxal-1.0418581 | 1.04 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 5H-Oxireno[4,5]furo[3,2-g][1]benzopyran-5-one,1a,8b-dihydro-3-methoxy- | 1.04 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glyoxylicacid-1.0549864 | 1.05 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyruvicacid-1.0565577 | 1.06 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Diglycolicacid | 1.06 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-KetoglutaricAcid | 1.07 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glutamate | 1.1 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-Naphthoicacidglucuronide | 1.11 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Acetoaceticacid | 1.11 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Dihydroquercetin | 1.11 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-methylene-4-oxo-pentanedioicacid | 1.13 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyruvicacid-1.1454303 | 1.15 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Purine-1.1716841 | 1.17 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | edetate-1.1820154 | 1.18 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | isoamylnitrite | 1.18 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glycine | 1.21 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyruvicacid-1.2166147 | 1.22 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pseudouridine | 1.23 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Furan2,5-dicarboxylicacid-1.2302623 | 1.23 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Dihydromyricetin | 1.24 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-Furoicacid-1.2499225 | 1.25 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Oxalaceticacid | 1.25 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Dehydroascorbicacid-1.251309 | 1.25 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2,3-Dioxogulonicacid | 1.25 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glutaconicacid-1.2568557 | 1.26 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyruvicacid-1.2594115 | 1.26 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Diacetyl-1.259489 | 1.26 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Uricacid | 1.27 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | alpha-Hydroxytriazolam | 1.27 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Ecgonine | 1.27 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glyoxylicacid-1.2737006 | 1.27 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Methylglyoxal-1.2775441 | 1.28 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyroglutamicacid-1.2783064 | 1.28 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Dihydroxyacetone(glycerone)-1.278433 | 1.28 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Methionine | 1.28 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Dehydroascorbicacid-1.285603 | 1.29 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ANHYDROBRAZILICACID | 1.34 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Uricacid-1.3627466 | 1.36 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Dihydroxyacetone(glycerone)-1.3661408 | 1.37 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-Hydroxy-2-naphthoicacid | 1.38 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Lactate | 1.43 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-Hydroxy-2-naphthoicacid-1.4369344 | 1.44 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Diacetyl-1.5030674 | 1.5 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyroglutamicacid-1.5171912 | 1.52 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glutaconicacid-1.5243738 | 1.52 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 4-Hydroxypyridine | 1.53 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Oxipurinol | 1.61 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 3-Dehydroquinicacid-1.6222234 | 1.62 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Oxipurinol-1.6762943 | 1.68 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Tyrosine | 1.71 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2,4-dihydroxy-2-heptenediocacid | 1.75 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Tyrosine-1.7685826 | 1.77 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Uridine | 1.87 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PenicillinG | 1.88 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Uridine-1.910261 | 1.91 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Erythrono-1,4-lactone-1.9339892 | 1.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Lactaldehyde | 1.94 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PenicillinG-1.967217 | 1.97 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Isoleucine | 2.06 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | beta-Alanine-2.075091 | 2.08 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Isoleucine-2.0780413 | 2.08 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-Naphthaleneaceticacid,6-hydroxy- | 2.26 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | a-hydroxybutyrate | 2.26 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | O-Desmethylnaproxen | 2.26 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Leucine | 2.27 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glucoheptonicacid | 2.29 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | L-arabitol | 2.29 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Lactaldehyde-2.5228448 | 2.52 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | a-hydroxybutyrate-2.5272808 | 2.53 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Diphenylmethylphosphineoxide | 2.53 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | O-Desmethylnaproxen-2.6572826 | 2.66 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | a-hydroxybutyrate-2.6625693 | 2.66 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-Hydroxy-2-naphthoicacid-2.7467046 | 2.75 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 4-Pyridoxicacid | 2.83 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-Methyluricacid | 2.9 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2,2-Dimethylsuccinicacid | 2.91 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyruvicacid-2.9096313 | 2.91 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-METHYLXANTHINE-3.0002494 | 3 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Ellagicacid | 3.05 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Ellagicacid-3.0542476 | 3.05 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-METHYLXANTHINE | 3.06 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-Hydroxy-2-naphthoicacid-3.09768 | 3.1 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Acetoin | 3.16 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-amino-4'-hydroxy-Propiophenone | 3.17 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2,3-Diaminopropionicacid | 3.17 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | p-HYDROXYCINNAMALDEHYDE | 3.17 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | MetLysSer | 3.17 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Cilastatin | 3.17 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Amoxicillin | 3.17 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | GlyAsnTyr | 3.17 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ISOLIQUIRITIGENIN | 3.17 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | SerAspGly | 3.19 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | a-hydroxyisovalerate | 3.21 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PantothenicAcid | 3.38 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1,3-Dimethyluricacid | 3.51 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Acetoin-3.5205564 | 3.52 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | a-hydroxyisovalerate-3.5221016 | 3.52 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyrocatecholsulfate | 3.56 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyrocatechol | 3.56 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-Hydroxy-2-naphthoicacid-3.6412473 | 3.64 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | METHYL7-DESHYDROXYPYROGALLIN-4-CARBOXYLATE | 3.65 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Tryptophan | 3.65 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Indole | 3.65 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Fluorescein | 3.66 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 3-Methyl-2-oxovalericacid | 3.67 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | b-Glucose | 3.68 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PenicillinG-3.6869733 | 3.69 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ,4-Dihydroxyphenylpropionicacid | 3.69 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Tolbutamide | 3.73 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | OSTHOL | 3.74 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Tetrahydrofuran | 3.74 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | O-Desmethylnaproxen-3.7390716 | 3.74 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Sedoheptulose | 3.79 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Phenol | 3.85 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 4-Hydroxybenzenesulfonicacid | 3.85 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 3-Methyl-2-oxovalericacid-3.889969 | 3.89 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Isovalericacid | 3.89 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Indoxylsulfuricacid | 4.13 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | AspAsnGlu | 4.32 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | B-ureidoisobutyricacid-4.3210588 | 4.32 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | N-gamma-Acetyl-N-2-formyl-5-methoxykynurenamine | 4.32 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Hippuricacid | 4.33 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | N-Acetylarylamine | 4.33 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-Hydroxy-2-naphthoicacid-4.3362813 | 4.34 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | N4-Acetylsulfapyridine | 4.34 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2,3-Dihydroxybenzoicacid | 4.42 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pyrocatechol-4.419533 | 4.42 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | p-Methylolphenol | 4.6 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | THIODIGLYCOL | 4.75 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | EMODICACID | 4.77 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | D-Leucicacid | 4.78 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Benzylalcohol | 4.8 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | EMODICACID-4.837887 | 4.84 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | N-Acetyl-5-aminosalicylicacid | 4.94 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-Ethylisonicotinicacid | 4.94 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | D-Phenyllacticacid | 5.14 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 5-Methoxyindoleacetate-5.326242 | 5.33 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 5-Methoxyindoleacetate | 5.33 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Diflunisal | 5.43 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | m-Salicylicacid | 5.43 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Phenol-5.4386764 | 5.44 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | guaifenesin | 5.46 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 3-Methylsubericacid | 5.74 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | IsoquinolineN-oxide | 5.75 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PSOROMICACID | 5.75 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ISOPIMPINELLIN | 5.76 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 19-hydroxy-17-oxoandrost-5-en-3-beta-ylsulfate | 5.91 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 3-Methylindole | 5.96 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 17-alpha,21-dihydroxy-11,20-dioxo-5-beta-pregnan-3-alpha-yl-beta-d-glucuronide | 6 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Ritodrineglucuronide | 6.1 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 3-Oxovalproicacid | 6.16 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 6-Hydroxynicotinicacid | 6.17 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | MetHisLys | 6.44 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2,4-DINITROPHENOL | 6.65 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PheArgSer | 6.67 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | LeuTyrMet | 6.68 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | b-D-Glucopyranosiduronicacid,(3b,5b)-17-oxoestran-3-yl | 6.68 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Phensuximide | 6.69 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PheArgGlu | 6.71 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Testosteronesulfate | 7.02 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 5beta-Androstan-3alpha-ol-17-onesulfate | 7.19 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Pregnanolonesulfate | 7.23 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 5beta-Androstan-3alpha-ol-17-onesulfate-7.384574 | 7.38 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Benzenemethanol,2-(2-aminopropoxy)-3-methyl- | 7.7 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-Hydroxy-3-(4-methoxyethylphenoxy)-propanoicacid | 7.7 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Bilirubin | 7.87 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 3E,5E-tridecadienoicacid | 8.03 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 10-oxo-decanoicacid | 8.06 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 10-hydroxycapricacid | 8.3 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-ISOPRENYL-3-HYDROXY-5-METHYL-a-PYRONE | 8.3 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glycoursodeoxycholicacid | 8.61 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 10-hydroxycapricacid-8.739356 | 8.74 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Glycoursodeoxycholicacid-8.816933 | 8.82 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-methyl-tridecanedioicacid | 8.86 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Embelin | 8.96 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | KOBUSONE | 8.96 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Procarbazine | 8.97 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | methyl9,11-epidioxy-12,15-dihydroperoxy-5,7,13-eicosatrienoate | 8.97 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | SerHisHis | 8.97 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | thyrotropinreleasinghormone | 8.97 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | methyl8-[2-(2-formyl-vinyl)-3-hydroxy-5-oxo-cyclopentyl]-octanoate | 9 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Methyljasmonate | 9.07 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 3-oxo-dodecanoicacid | 9.11 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | gamma-Hydroxyphenylbutazoneglucuronide | 9.54 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ROTENONICACID,METHYLETHER | 9.56 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Ubiquinone | 9.57 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Embelin-9.58408 | 9.58 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | O-BENZYL-l-SERINE | 9.6 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ValMetCys | 9.62 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 5-(4-hydroxy-2,5-dimethylphenoxy)-2,2-dimethyl-Pentanoicacid(GemfibrozilM1) | 9.62 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | CysThrArg | 9.62 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-Hydroxyethinylestradiol | 10.05 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Murocholicacid | 10.1 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 6b,11b,16a,17a,21-Pentahydroxypregna-1,4-diene-3,20-dione16,17-acetonide | 10.1 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ArgCysPhe | 10.11 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 6b,11b,16a,17a,21-Pentahydroxypregna-1,4-diene-3,20-dione16,17-acetonide-10.120011 | 10.12 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ArgCysPhe-10.132811 | 10.13 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 6b,11b,16a,17a,21-Pentahydroxypregna-1,4-diene-3,20-dione16,17-acetonide-10.308402 | 10.31 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | DIHYDROMUNDULETONE | 10.31 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-Hydroxyethinylestradiol-10.318296 | 10.32 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Desmosine | 10.53 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Isoacitretin | 10.6 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ArgPheArg | 10.62 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ProTrpHis | 10.64 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | clavuloneI | 10.65 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ProTrpHis-10.727135 | 10.73 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Isoacitretin-10.753435 | 10.75 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ProTrpIle | 10.81 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Sodiumtetradecylsulfate | 10.81 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | clavuloneI-10.898006 | 10.9 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Isoacitretin-10.899509 | 10.9 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | D1-2-Hydroxymethylethisterone | 11.16 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | TRIDESACETOXYKHIVORIN | 11.18 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | GPSer(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 11.21 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | GemfibrozilM2 | 11.25 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | D1-2-Hydroxymethylethisterone-11.350735 | 11.35 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | D1-2-Hydroxymethylethisterone-11.471997 | 11.47 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Lauricacid | 11.85 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Panaxytriol | 11.94 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Panaxytriol-11.995774 | 12 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | DL-11-hydroxystearicacid | 12.09 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 9R-hydroxy-12E-octadecenoicacid | 12.37 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1alpha,25-dihydroxy-2beta-(5-hydroxypentoxy)vitaminD3/1alpha,25-dihydroxy-2beta-(5-hydroxypentoxy | 12.62 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 9,12,14-octadecatrienoicacid | 12.79 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 3-hydroxy-hexadecanoicacid | 12.82 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 3,9,15-Docosatriynoicacid | 13.05 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 4,8-dimethyl-dodecanoicacid | 13.07 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 7-palmitoleicacid | 13.23 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 4Z,7Z,10Z,13Z-eicosatetraenoicacid | 13.28 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 4,7,10,13,16-docosapentaenoicacid | 13.41 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | D1-2-Hydroxymethylethisterone-13.439987 | 13.44 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 13E,17-octadecadienoicacid | 13.46 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | ArgAsnGln | 13.46 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 4,7,10,13,16-docosapentaenoicacid-13.522585 | 13.52 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1,2-di-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycerol | 13.6 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | (22S)-1alpha,22,25-trihydroxy-23,24-tetradehydro-24a,24b-dihomo-20-epivitaminD3/(22S)-1alpha,22,2 | 13.6 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Isopentadecylicacid | 13.62 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Embelin-13.636489 | 13.64 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1alpha,25-dihydroxy-26,27-dimethyl-22-oxavitaminD3/1alpha,25-dihydroxy-26,27-dimethyl-22-oxachole | 13.64 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 5Z,11Z,14Z-eicosatrienoicacid | 13.73 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1alpha,25-dihydroxy-26,27-dimethyl-22-oxavitaminD3/1alpha,25-dihydroxy-26,27-dimethyl-22-oxachole-13.7853775 | 13.79 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-Hydroxyethinylestradiol-13.812337 | 13.81 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Embelin-13.931011 | 13.93 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-propyl-tridecanoicacid | 14.09 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Cholesterolsulfate | 14.1 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Isoacitretin-14.103292 | 14.1 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1alpha,25-dihydroxy-11alpha-phenylvitaminD3/1alpha,25-dihydroxy-11alpha-phenylcholecalciferol | 14.12 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PGH2 | 14.13 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | PheAlaArg | 14.14 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 9-deoxy-9-methylene-16,16-dimethyl-PGE2 | 14.17 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 5-octadecylenicacid | 14.22 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | D1-2-Hydroxymethylethisterone-14.223754 | 14.22 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Embelin-14.229529 | 14.23 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-Hydroxyethinylestradiol-14.280895 | 14.28 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1alpha,25-dihydroxy-11alpha-phenylvitaminD3/1alpha,25-dihydroxy-11alpha-phenylcholecalciferol-14.324497 | 14.32 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Stearicacid | 14.34 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Embelin-14.352174 | 14.35 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Hexacosanedioicacid | 14.5 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 2-propyl-tridecanoicacid-14.579373 | 14.58 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | GPEtn(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 14.64 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 1-(13Z-docosenoyl)-2-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycerol | 14.65 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | 10-methyl-hexadecanoicacid | 14.66 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Embelin-14.664187 | 14.66 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood | |
| AN000078 | Bilirubin-14.711075 | 14.71 | Minutes | ST000046 | NEGATIVE | Agilent 6220 TOF | Reversed phase | Human | Blood |
